PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,515,506 | -24.6% | 1,017,958 | -4.4% | 0.23% | -22.1% |
| Q2 2023 | $13,952,776 | -48.1% | 1,064,285 | -55.7% | 0.30% | -50.3% |
| Q1 2023 | $26,862,231 | -56.7% | 2,402,704 | -35.4% | 0.60% | -51.5% |
| Q3 2022 | $61,990,000 | +21.5% | 3,720,901 | +7.4% | 1.23% | +17.3% |
| Q2 2022 | $51,018,000 | -44.4% | 3,465,901 | -6.2% | 1.05% | -48.7% |
| Q1 2022 | $91,681,000 | +20.8% | 3,695,341 | +56.1% | 2.05% | +28.8% |
| Q4 2021 | $75,905,000 | +3.9% | 2,366,867 | +16.6% | 1.59% | +11.7% |
| Q3 2021 | $73,035,000 | -8.1% | 2,029,887 | +12.7% | 1.42% | +1.0% |
| Q2 2021 | $79,455,000 | +85.4% | 1,800,887 | +92.2% | 1.41% | +56.6% |
| Q1 2021 | $42,860,000 | +34.0% | 937,032 | +102.2% | 0.90% | +42.6% |
| Q4 2020 | $31,992,000 | – | 463,511 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |